US based 3M is in talks with Indian pharma companies to license tech technologies
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
Say something
US based 3M is in talks with Indian pharma companies to license tech technologies
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
-
-
Flipkart Health+ App Launched
06-04-2022
